Mirada, TMCS partner for Fusion7D sales in Japan

TriMed Staff | | Health Imaging | Molecular Imaging
Mirada Solutions Ltd., a subsidiary of CTI Molecular Imaging Inc., this week finalized a distribution and development partnership with Toshiba Medical Systems Corp. (TMSC) of Japan. The agreement allows the distribution of Mirada's Fusion7D PET (positron emission tomography) and image fusion platform in Japan as part of TMSC's nuclear medicine and PET workstation offering.

While additional terms were not released, Mirada says the agreement represents a significant distribution relationship in one of the strongest emerging PET markets.

TriMed Staff

Related Content

Researchers receive grant worth millions to develop portable PET scanner
Why is the US still dependent on foreign medical isotope production?
Downed high-flux reactor could restart sooner than anticipated
Some nuc med departments are already feeling the strain of the isotope shortage
NorthStar opens facility to assist with development and distribution of vital radioisotopes
Lizard saliva could be key to spotting elusive pancreatic tumors

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.